This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Feb;93(2):111-2.

doi: 10.1038/icb.2014.111. Epub 2015 Jan 6.

Is DUBA putting the brake on Th17 cells?

Anne Brüstle¹

Affiliations

PMID: 25559621
DOI: 10.1038/icb.2014.111

Comment

Is DUBA putting the brake on Th17 cells?

Anne Brüstle. Immunol Cell Biol. 2015 Feb.

. 2015 Feb;93(2):111-2.

doi: 10.1038/icb.2014.111. Epub 2015 Jan 6.

Author

Anne Brüstle¹

Affiliation

¹ Department of Pathogens and Immunity, John Curtin School of Medical Research, The Australian National University, Canberra, Australia.

PMID: 25559621
DOI: 10.1038/icb.2014.111

No abstract available

PubMed Disclaimer

Comment on

Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells.
Rutz S, Kayagaki N, Phung QT, Eidenschenk C, Noubade R, Wang X, Lesch J, Lu R, Newton K, Huang OW, Cochran AG, Vasser M, Fauber BP, DeVoss J, Webster J, Diehl L, Modrusan Z, Kirkpatrick DS, Lill JR, Ouyang W, Dixit VM. Rutz S, et al. Nature. 2015 Feb 19;518(7539):417-21. doi: 10.1038/nature13979. Epub 2014 Dec 3. Nature. 2015. PMID: 25470037

References

1. Trends Pharmacol Sci. 2014 Oct;35(10):493-500 - PubMed
1. Autoimmun Rev. 2014 Dec;13(12):1174-81 - PubMed
1. Nature. 2010 Oct 21;467(7318):967-71 - PubMed
1. J Clin Invest. 2012 Dec;122(12 ):4698-709 - PubMed
1. Nature. 2015 Feb 19;518(7539):417-21 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley